Skip to main content
Go to the home page of the European Commission (opens in new window)
English English
CORDIS - EU research results
CORDIS
Content archived on 2024-06-10

Engineering anti-tumour biosynthetic pathways to generate novel anti-tumour drugs

Objective



The aim of the project is to generate novel hybrid molecules, potentially showing anti-tumour activity, by engineering several pathways involved in the biosynthesis of anti-tumour drugs by streptomycetes. The target drugs for engineering will be the angucyclines (urdamycins), the aureolic acid group (mithramycin, chromomycin and olivomycin), the anthracyclines group and elloramycin and tetracenomycin. Gene clusters (or specific genes) involved in the biosynthesis of these anti-tumour drugs will be isolated and sequenced to identify potential gene functions and they will be used for interspecific exchange experiments to create new hybrid gene constructions. Novel molecules synthesised by these clones will be identified, isolated and their structures elucidated. Mutants blocked at specific steps of the biosynthesis will be also generated by gene replacement techniques and the accumulated products isolated and structurally identified. These accumulated products will be used for directed biosynthesis of specific strains or mutants to generate new compounds. Gene clusters will be also introduced into a streptomycete strain able to synthesise fluoroacetate such that fluoroacetate may be used as starter unit to generate modified molecules. In addition, new molecules will be also generated by feeding specific strains with compounds derived from polyketide model systems. Potential cytostatic activity of the novel molecules will be assayed using different tumour cell lines. The experimental approach used in this proposal will be a co-ordinated, multi-disciplinary study using molecular biology, organic chemistry and cell cultures and will involve five university research groups and two small/medium sized enterprises. Achievements of the goal of the project will have important biotechnological implications and could directly benefit the european pharmaceutical sector interested in anti-tumour drugs.

Fields of science (EuroSciVoc)

CORDIS classifies projects with EuroSciVoc, a multilingual taxonomy of fields of science, through a semi-automatic process based on NLP techniques. See: The European Science Vocabulary.

You need to log in or register to use this function

Programme(s)

Multi-annual funding programmes that define the EU’s priorities for research and innovation.

Topic(s)

Calls for proposals are divided into topics. A topic defines a specific subject or area for which applicants can submit proposals. The description of a topic comprises its specific scope and the expected impact of the funded project.

Call for proposal

Procedure for inviting applicants to submit project proposals, with the aim of receiving EU funding.

Data not available

Funding Scheme

Funding scheme (or “Type of Action”) inside a programme with common features. It specifies: the scope of what is funded; the reimbursement rate; specific evaluation criteria to qualify for funding; and the use of simplified forms of costs like lump sums.

CSC - Cost-sharing contracts

Coordinator

UNIVERSIDAD DE OVIEDO
EU contribution
No data
Address
S/N,Julian Claveria s/n
33006 Oviedo
Spain

See on map

Total cost

The total costs incurred by this organisation to participate in the project, including direct and indirect costs. This amount is a subset of the overall project budget.

No data

Participants (6)

My booklet 0 0